Navigation Links
Octapharma Joins Biotechnology Industry Organization
Date:1/25/2008

CENTREVILLE, Va., Jan. 25 /PRNewswire/ -- Octapharma is pleased to announce its decision to become a member of the Biotechnology Industry Organization. Membership in BIO brings substantial benefits to Octapharma. Among these is the Association's considerable influence on the U.S. legislative process and on regulatory bodies. Representing some of the largest and most research intensive pharmaceutical companies, BIO's voice is heard where smaller groups are not. With reimbursement of biologicals becoming a significant problem in patient access to product, this influence will be critical in providing essential input into federal and state reimbursement policies and resolving access issues.

Additionally, BIO has made a concerted effort to develop a constituency of plasma derivative manufacturers. For those plasma derivative manufacturers who are currently members, BIO has become a leading source of advanced information on government and private policies relevant to the plasma derivative industry. BIO also coordinates its policy position with patient groups though its Outreach/Alliance Development Committee and other mechanisms that host regular briefings, tours and recognition events for health advocacy groups.

Finally, Octapharma believes that its decision to join BIO is consistent with its future plans and with its new mission statement, "for the safe and optimal use of human proteins." With much of the BIO membership focusing on leading edge research in genetic modifications of peptides and proteins, bioprocessing, and bioinformatics, there would appear to be great opportunities for commercial collaboration and cross-fertilization.

Octapharma welcomes the opportunity to be a part of this leading Association!

Octapharma is a leading provider of human plasma based biopharmaceuticals to healthcare professionals and consumers worldwide. Since its founding in 1983, the name Octapharma has become synonymous with ethical and responsible provision of healthcare products. We manufacture products of proven efficacy, quality and safety. More information about Octapharma can be found at http://www.octapharma.com.


'/>"/>
SOURCE Octapharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
2. Advanced Medical Specialties Joins US Oncology Network
3. Former Patent Office Solicitor and Judge Joins Rothwell Figg
4. William Garland Joins AngioGenexs New Board of Directors
5. Robin C. Stracey Joins Cantimer, Inc. as President and CEO
6. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
7. Jim Dorst Joins SpectraScience as CFO
8. Chambers Joins PRA International as Senior Vice President of Human Resources
9. Brian J.G. Pereira, M.D. Joins Biodels Board of Directors
10. Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research
11. SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
(Date:6/22/2016)...   StockNewsNow.com , The Official MicroCap News Source™, ... Nader Pourhassan , President & CEO of CytoDyn Inc. ... development and potential commercialization of humanized monoclonal antibodies for ... the company,s website (see here: www.CytoDyn.com ). The ... , 2016, at the LD Micro Invitational in ...
(Date:6/22/2016)... ... , ... New light-based technologies that facilitate a “look inside” the human body ... compact, wearable devices for point-of-care diagnostics as well as powerful new systems that provide ... visionary future directions are detailed in a new open-access article by Antonio Pifferi and ...
(Date:6/22/2016)... ALBANY, N.Y. , June 22, 2016 ... Molecular Research, Inc. (NASDAQ: AMRI ) ... to produce and sell the first commercially available ... standard is manufactured using Teewinot,s patented biosynthetic processes. ... biosynthetic genes in microorganisms for efficient production of ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
Breaking Biology News(10 mins):